Skip to research
Margin Monkey THEMARGINMONKEY Start my free trialTry free

Merit Medical Systems (MMSI) stock in plain English

Free brief · no signupStart here
MMSIPublished Nov 13, 2026
Merit Medical Systems Inc
Healthcare · Medical Instruments & Supplies
Manufactures and sells disposable medical devices used for cardiology, radiology, oncology, and vascular surgery.
Assets:
Worldwide manufacturingOperates major production plants across Utah, Ireland, Mexico, and Singapore.
Extensive patent portfolioOwns thousands of active utility and design patents protecting proprietary catheters.
Global workforceEmploys over seven thousand full-time staff across direct sales and cleanroom manufacturing.
Locked assetIn the full report
Rated Nov 19, 2026

Every company we rate gets Strong Buy, Buy, Buy with Caution, Hold or Sell. Members see the rating for this company and the five scores behind it.

72
OPS ScoreOperating finances
Latest quote
-1.77%$84.41
$5.06B
31.7×
$1.61B

Change shown by the quote provider. Data may be delayed.

Financial statements, in plain wordsSales, profit, debt and cash, year by year
Published Nov 13, 2026Quotes updated Nov 20, 04:05 UTCOPS Score, TMM Score and the rating are research summaries, not advice or forecasts.
That was MMSI. The desk has 1,900+ more companies.Each one comes with its scores, its flags and the sources behind them.
7 days free · No card

What does Merit Medical Systems (MMSI) do?

Merit Medical Systems Inc (MMSI) is a U.S.-listed company in Healthcare (Medical Instruments & Supplies). What it does: Manufactures and sells disposable medical devices used for cardiology, radiology, oncology, and vascular surgery. It manufactures custom disposable procedure kits and specialized catheters across its own global factories. It is worth $5.06B on the market and sold $1.61B over the last year.

Market cap
$5.06B
P/E ratio
31.7×
Annual sales
$1.61B
Sector
Healthcare
Industry
Medical Instruments & Supplies
Brief updated
Nov 13, 2026

Brands and businesses behind MMSI

  • SCOUT: Sells radar breast localization reflectors and consoles to surgeons for identifying soft tissue tumors during surgery.
  • Embosphere: Produces biocompatible microspheres sold to interventional radiologists to block blood flow to targeted tumors.
  • Prelude: Sells specialized vascular sheath introducers to hospitals for catheter access during cardiovascular procedures.
  • HeRO Graft: Provides surgically implanted dialysis access devices directly to clinics treating end-stage renal disease.

MMSI’s flags, in plain English

Each flag is a number from Merit Medical Systems’ reports to the SEC or from market data, with the reason it matters. This brief was updated on Nov 13, 2026.

Stupid Cash

Can pay this year's bills 4.5 times over. Cash in the bank covers a long stretch of running costs. The company can fund itself without borrowing or selling new shares.

Low debt

Low debt, only 47% of shareholder equity. The company owes very little compared with what it earns, so a bad year is less likely to force its hand.

Wide Gross Margin

Gross margin of 49.4% after the cost of making its products. There is a large gap between what its products cost to make and what they sell for, and that gap pays for everything else.

Leans on One Supplier

The company relies on single-source suppliers for several specialized medical-grade polymers and metals. It depends on a supplier or partner that would be hard to replace, so trouble there could hit the whole business.

1 more green flag open with the free trial. Try it free for 7 days.

Questions about MMSI

How big is Merit Medical Systems?

Merit Medical Systems’ market cap is $5.06B: what all of its shares are worth together at today’s price. Its annual sales (revenue) are $1.61B: what customers paid the company over the last year, before any costs.

What is MMSI’s P/E ratio?

MMSI’s P/E ratio is 31.7×. Investors pay about 31.7 dollars for each dollar of the company’s yearly profit. A low number can mean a bargain or a problem, so read it next to the flags.

What could go wrong with MMSI?

The first risk note on the card is Leans on One Supplier, explained above. A flag reads what the company reported. It does not predict the price.

Where do these numbers come from?

From Merit Medical Systems’ own reports to the SEC (annual and quarterly) and from market data. Every company runs through the same scoring formula, and a reviewer spot-checks cards against the source data. MMSI’s filings on SEC.gov. The Margin Monkey is research, not advice.

Your first 7 days are free.Search all 1,900+ companies and open every card. Members also get the ratings, Picks and the TMM Score.
7 days free · No card